Item 16. FORM 10-K SUMMARY

5K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


						AMERISOURCEBERGEN CORPORATION
Date: November 22, 2022						By:						/s/ STEVEN H. COLLIS Steven H. Collis Chairman, President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below as of November 22, 2022 by the following persons on behalf of the Registrant and in the capacities indicated.


Signature						Title

/s/ STEVEN H. COLLIS___________________________ Steven H. Collis						Chairman, President and Chief Executive Officer (Principal Executive Officer)

/s/ JAMES F. CLEARY____________________________ James F. Cleary						Executive Vice President and Chief Financial Officer (Principal Financial Officer)

/s/ LAZARUS KRIKORIAN________________________ Lazarus Krikorian						Senior Vice President and Chief Accounting Officer (Principal Accounting Officer)

/s/ ORNELLA BARRA____________________________ Ornella Barra						Director

/s/ D. MARK DURCAN____________________________ D. Mark Durcan						Director

/s/ RICHARD W. GOCHNAUER____________________ Richard W. Gochnauer						Director

/s/ LON R. GREENBERG__________________________ Lon R. Greenberg						Director


Signature						Title

/s/ JANE E. HENNEY, M.D.________________________ Jane E. Henney, M.D.						Lead Independent Director

/s/ KATHLEEN W. HYLE__________________________ Kathleen W. Hyle						Director

/s/ LORENCE H. KIM, M.D._______________________ Lorence H. Kim, M.D.						Director

/s/ MICHAEL J. LONG____________________________ Michael J. Long						Director

/s/ HENRY W. MCGEE____________________________ Henry W. McGee						Director

/s/ DENNIS M. NALLY____________________________ Dennis M. Nally						Director

AMERISOURCEBERGEN CORPORATION AND SUBSIDIARIES

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS


(In thousands)	Balance at Beginning of Period		Charged to Costs and Expenses (1)		Deductions (2)		Balance at End of Period
Year Ended September 30, 2022
Allowances for returns and credit losses	$	1,356,684	$	5,124,081	$	(4,854,036)	$	1,626,729

Year Ended September 30, 2021
Allowances for returns and credit losses	$	1,417,308	$	3,906,776	$	(3,967,400)	$	1,356,684

Year Ended September 30, 2020
Allowances for returns and credit losses	$	1,223,887	$	4,019,830	$	(3,826,409)	$	1,417,308

(1)Represents the provision for returns and credit losses.

(2)Represents reductions to the returns allowance and accounts receivable written off during year, net of recoveries.

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES